- Harrison.ai raises AU$129 million (USD$97 million) in Series B funding, marking one of Australia’s largest funding rounds.
- Partnership formed with Sonic Healthcare to develop and commercialize clinical AI solutions in pathology.
- Funding to expand AI team and venture into new healthcare areas globally.
- Collaboration addresses skills shortages in diagnostic healthcare, particularly in pathology.
- Joint venture aims to revolutionize diagnostic care with AI-driven solutions.
- Market sees transformative potential in technology for equitable and efficient healthcare delivery.
Main AI News:
In a monumental move for Australia’s tech and healthcare sectors, Harrison.ai has successfully raised AU$129 million (USD$97 million) in one of the country’s largest Series B funding rounds to date. This influx of capital signifies a significant leap forward in Harrison.ai’s mission to bolster critical capacity within the global healthcare system through the rapid commercialization of comprehensive clinical AI applications.
A key highlight of this development is the strategic partnership with Sonic Healthcare, a renowned leader in medical diagnostics. Together, Harrison.ai and Sonic Healthcare will embark on a collaborative journey to co-develop and commercialize innovative clinical AI solutions in the field of pathology. This partnership not only underscores a commitment to advancing healthcare technology but also heralds a new era of efficiency and accuracy in diagnostic care.
The substantial funding secured by Harrison.ai will be allocated towards bolstering its team of AI data scientists and engineers, as well as expanding into new realms of healthcare in collaboration with global clinical partners. This strategic investment, supported by a blend of global investors like Horizons Ventures alongside key clinical stakeholders, positions Harrison.ai to expand its global footprint while harnessing invaluable medical expertise and reach.
Dr. Aengus Tran, Co-Founder and CEO of Harrison.ai, emphasized the paramount importance of delivering equitable, effective, and accurate healthcare, especially in the wake of the pandemic. With Harrison.ai’s proven model and methodology spanning multiple clinical domains, the company is poised to venture into new clinical territories and fulfill its mission with unwavering support from investors and partners alike.
The partnership with Sonic Healthcare represents a pivotal milestone in Harrison.ai’s quest for equitable healthcare delivery. By leveraging Harrison.ai’s expertise in conjunction with Sonic Healthcare’s clinical acumen and expansive distribution network, the collaboration aims to swiftly commercialize AI-driven solutions in pathology, thereby revolutionizing diagnostic care on a global scale.
Pathology, a field already grappling with a severe skills shortage worldwide, stands to benefit immensely from the development of comprehensive AI solutions. Despite a surge in workload, the number of pathologists in the US has dwindled significantly in recent years, underscoring the urgent need for innovative solutions to bridge this gap. Harrison.ai’s collaboration with Sonic Healthcare promises to address this challenge head-on, empowering clinicians with the tools needed to diagnose patients more effectively and efficiently.
Dr. Colin Goldschmidt, CEO of Sonic Healthcare, hailed the formation of the joint venture with Harrison.ai as a pivotal moment in Sonic Healthcare’s evolution as a healthcare powerhouse. With Harrison.ai’s prowess in AI technology complementing Sonic Healthcare’s clinical prowess, the partnership is primed to drive unprecedented advancements in diagnostic healthcare.
Conclusion:
The partnership between Harrison.ai and Sonic Healthcare, coupled with Harrison.ai’s substantial funding, signifies a monumental leap forward in the global healthcare market. By addressing critical skills shortages and harnessing the power of AI technology, this collaboration has the potential to revolutionize diagnostic care, setting a new standard for equitable and efficient healthcare delivery worldwide.
